D-1172-2023 Class III Terminated

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-1172-2023 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Sep 7, 2023 and is designated Class III. Reason for recall: Subpotent: Out of Specification result observed for low assay The recall status is terminated (terminated Feb 13, 2024). Affected quantity: 69,707 cartons.

Recall details

Product Type
Drugs
Report Date
Sep 27, 2023
Initiation Date
Sep 7, 2023
Termination Date
Feb 13, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
69,707 cartons

Product description

Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France NDC 47335-506-96

Reason for recall

Subpotent: Out of Specification result observed for low assay

Distribution pattern

Nationwide wide in the USA

Code information

Lot# 10026, Lot 10027, Exp. 09/2023.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1172-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1172-2023. Report a data issue: hello@regdatalab.com.